Renewal of the T-cell compartment in multiple sclerosis patients treated with glatiramer acetate

Multiple Sclerosis

Volumn 16, Issue 2, 2010, Pages 218-227

  Chiarini, M ^a   Sottini, A ^a   Ghidini, C ^a   Zanotti, C ^a   Serana, F ^b   Rottoli, M ^c   Zaffaroni, M ^d   Bergamaschi, R ^e   Cordioli, C ^f   Capra, R ^f   Imberti, L ^a  

^a Laboratorio di Biotecnologie   (Italy)

^b UNIVERSITY OF BRESCIA   (Italy)

^c OSPEDALI RIUNITI   (Italy)

^d Ospedale di Gallarate   (Italy)

^e C MONDINO NATIONAL NEUROLOGICAL INSTITUTE   (Italy)

^f SPEDALI CIVILI   (Italy)

Author keywords

Disease modifying therapies; Glatiramer acetate; Immunologic monitoring; Immunology; Multiple sclerosis; T cell receptor; T cells; Thymicnaive T helper cells

Indexed keywords

GLATIRAMER; T LYMPHOCYTE RECEPTOR;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DNA EXTRACTION; DRUG MECHANISM; FOLLOW UP; HELPER CELL; HUMAN; IMMUNOMODULATION; IMMUNOPHENOTYPING; MAJOR CLINICAL STUDY; MEMORY T LYMPHOCYTE; MULTIPLE SCLEROSIS; NONHUMAN; T LYMPHOCYTE; THYMUS;

ADOLESCENT; ADULT; AGED; CASE-CONTROL STUDIES; FLOW CYTOMETRY; HUMANS; IMMUNOLOGIC FACTORS; IMMUNOLOGIC MEMORY; IMMUNOPHENOTYPING; LYMPHOPOIESIS; MIDDLE AGED; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; PEPTIDES; POLYMERASE CHAIN REACTION; RECEPTORS, ANTIGEN, T-CELL; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, HELPER-INDUCER; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 76449085393     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1177/1352458509355460     Document Type: Article

References (45)

1. Duda PW, Krieger JI, Schmied MC, Balentine C., Hafler DA Human and murine CD4 T cell reactivity to a complex antigen: recognition of the synthetic random polypeptide glatiramer acetate. J Immunol 2000 ; 165: 7300-7307.
2. Neuhaus O., Farina C., Yassouridis A., et al. Multiple sclerosis: Comparison of copolymer-1- reactive T cell lines from treated and untreated subjects reveals cytokine shift from T helper 1 to T helper 2 cells. Proc Natl Acad Sci U S A 2000 ; 97: 7452-7457.
3. Farina C., Weber MS, Meinl E., Wekerle H., Hohlfeld R. Glatiramer acetate in multiple sclerosis: update on potential mechanisms of action. Lancet Neurol 2005 ; 4: 567-575.
4. Holbrook MR, Tighe PJ, Powell RJ Restrictions of T cell receptor beta chain repertoire in the peripheral blood of patients with systemic lupus erythematosus. Ann Rheum Dis 1996 ; 55: 627-631.
5. Imberti L., Sottini A., Signorini S., Gorla R., Primi D. Oligoclonal CD4+ CD57+ T-cell expansions contribute to the imbalanced T-cell receptor repertoire of rheumatoid arthritis patients. Blood 1997 ; 89: 2822-2832.
6. Wagner UG, Koetz K., Weyand CM, Goronzy JJ Perturbation of the T cell repertoire in rheumatoid arthritis. Proc Natl Acad Sci U S A 1998 ; 95: 14447-14452.
7. Martin A., Barbesino G., Davies TF T-cell receptors and autoimmune thyroid disease - signposts for T-cell-antigen driven diseases. Int Rev Immunol 1999 ; 18: 111-140.
8. Kotzin BL, Karuturi S., Chou YK, et al. Preferential T-cell receptor beta-chain variable gene use in myelin basic protein-reactive T-cell clones from patients with multiple sclerosis. Proc Natl Acad Sci U S A 1991 ; 88: 9161-9165.
9. Oksenberg JR, Panzara MA, Begovich AB, et al. Selection for T-cell receptor V beta-D beta-J beta gene rearrangements with specificity for a myelin basic protein peptide in brain lesions of multiple sclerosis. Nature 1993 ; 362: 68-70.
10. Gran B., Gestri D., Sottini A., et al. Detection of skewed T-cell receptor V-beta gene usage in the peripheral blood of patients with multiple sclerosis. J Neuroimmunol 1998 ; 85: 22-32.
11. Muraro PA, Bonanni L., Mazzanti B., et al. Short-term dynamics of circulating T cell receptor V beta repertoire in relapsing-remitting MS. J Neuroimmunol 2002 ; 127: 149-159.
12. Matsumoto Y., Yoon WK, Jee Y., et al. Complementarity-determining region 3 spectratyping analysis of the TCR repertoire in multiple sclerosis. J Immunol 2003 ; 170: 4846-4853.
13. Hug A., Korporal M., Schröder I., et al. Thymic export function and T cell homeostasis in patients with relapsing remitting multiple sclerosis. J Immunol 2003 ; 171: 432-437.
14. Berzins SP, Godfrey DI, Miller JF, Boyd RL A central role for thymic emigrants in peripheral T cell homeostasis. Proc Natl Acad Sci U S A 1999 ; 96: 9787-9791.
15. Kimmig S., Przybylski GK, Schmidt CA, et al. Two subsets of naive T helper cells with distinct T cell receptor excision circle content in human adult peripheral blood. J Exp Med 2002 ; 195: 789-794.
16. Torimoto Y., Rothstein DM, Dang NH, Schlossman SF, Morimoto C. CD31, a novel cell surface marker for CD4 cells of suppressor lineage, unaltered by state of activation. J Immunol 1992 ; 148: 388-396.
17. Sallusto F., Lenig D., Förster R., Lipp M., Lanzavecchia A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 1999 ; 401: 708-712.
18. McDonald WI, Compston A., Edan G., et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 2001 ; 50: 121-127.
19. Capra R., Sottini A., Cordioli C., et al. IFNbeta bioavailability in multiple sclerosis patients: MxA versus antibody-detecting assays. J Neuroimmunol 2007 ; 189: 102-110.
20. Akatsuka Y., Martin EG, Madonik A., Barsoukov AA, Hansen JA Rapid screening of T-cell receptor (TCR) variable gene usage by multiplex PCR: application for assessment of clonal composition. Tissue Antigens 1999 ; 53: 122-134.
21. Gorochov G., Neumann AU, Kereveur A., et al. Perturbation of CD4+ and CD8+ T-cell repertoires during progression to AIDS and regulation of the CD4+ repertoire during antiviral therapy. Nat Med 1998 ; 4: 215-221.
22. Douek DC, McFarland RD, Keiser PH, et al. Changes in thymic function with age and during the treatment of HIV infection. Nature 1998 ; 396: 690-695.
23. Zhang L., Lewin SR, Markowitz M., et al. Measuring recent thymic emigrants in blood of normal and HIV-1-infected individuals before and after effective therapy. J Exp Med 1999 ; 190: 725-732.
24. Muraro PA, Cassiani-Ingoni R., Chung K., Packer AN, Sospedra M., Martin R. Clonotypic analysis of cerebrospinal fluid T cells during disease exacerbation and remission in a patient with multiple sclerosis. J Neuroimmunol 2006 ; 171: 177-183.
25. Comi G., Filippi M., Wolinsky JS European/Canadian multicenter, double-blind, randomized, placebo-controlled study of the effects of glatiramer acetate on magnetic resonance imaging - measured disease activity and burden in patients with relapsing multiple sclerosis. European/ Canadian Glatiramer Acetate Study Group. Ann Neurol 2001 ; 49: 290-297.
26. Meinl E., Hohlfeld R. Immunopathogenesis of multiple sclerosis: MBP and beyond. Clin Exp Immunol 2002 ; 128: 395-397.
27. Muraro PA, Douek DC, Packer A., et al. Thymic output generates a new and diverse TCR repertoire after autologous stem cell transplantation in multiple sclerosis patients. J Exp Med 2005 ; 201: 805-816.
28. Duszczyszyn DA, Beck JD, Antel J., et al. Altered naive CD4 and CD8 T cell homeostasis in patients with relapsing-remitting multiple sclerosis: thymic versus peripheral (non-thymic) mechanisms. Clin Exp Immunol 2006 ; 143: 305-313.
29. Puissant-Lubrano B., Viala F., Winterton P., Abbal M., Clanet M., Blancher A. Thymic output and peripheral T lymphocyte subsets in relapsing-remitting multiple sclerosis patients treated or not by IFN-beta. J Neuroimmunol 2008 ; 193: 188-194.
30. Thewissen M., Linsen L., Somers V., Geusens P., Raus J., Stinissen P. Premature immunosenescence in rheumatoid arthritis and multiple sclerosis patients. Ann N Y Acad Sci 2005 ; 1051: 255-262.
31. Hazenberg MD, Verschuren MC, Hamann D., Miedema F., van Dongen JJ T cell receptor excision circles as markers for recent thymic emigrants: basic aspects, technical approach, and guidelines for interpretation. J Mol Med 2001 ; 79: 631-640.
32. Cavazzana-Calvo M., Carlier F., Le Deist F., et al. Long-term T-cell reconstitution after hematopoietic stem-cell transplantation in primary T-cell-immunodeficient patients is associated with myeloid chimerism and possibly the primary disease phenotype. Blood 2007 ; 109: 4575-4581.
33. Mazzolari E., Forino C., Guerci S., et al. Long-term immune reconstitution and clinical outcome after stem cell transplantation for severe T-cell immunodeficiency. J Allergy Clin Immunol 2007 ; 120: 892-899.
34. Benicchi T., Ghidini C., Re A., et al. T-cell immune reconstitution after hematopoietic stem cell transplantation for HIV-associated lymphoma. Transplantation 2005 ; 80: 673-682.
35. Kohler S., Thiel A. Life after the thymus: CD31+ and CD31- human naive CD4+ T-cell subsets. Blood 2009 ; 113: 769-774.
36. Mackall CL, Fleisher TA, Brown MR, et al. Age, thymopoiesis, and CD4+ T-lymphocyte regeneration after intensive chemotherapy. N Engl J Med 1995 ; 332: 143-149.
37. Dion ML, Poulin JF, Bordi R., et al. HIV infection rapidly induces and maintains a substantial suppression of thymocyte proliferation. Immunity 2004 ; 21: 757-768.
38. Hazenberg MD, Otto SA, Cohen Stuart JW, et al. Increased cell division but not thymic dysfunction rapidly affects the T-cell receptor excision circle content of the naive T cell population in HIV-1 infection. Nat Med 2000 ; 6: 1036-1042.
39. Naylor K., Li G., Vallejo AN, et al. The influence of age on T cell generation and TCR diversity. J Immunol 2005 ; 174: 7446-7452.
40. Fridkis-Hareli M., Teitelbaum D., Gurevich E., et al. Direct binding of myelin basic protein and synthetic copolymer 1 to class II major histocompatibility complex molecules on living antigen-presenting cells - specificity and promiscuity. Proc Natl Acad Sci USA 1994 ; 91: 4872-4876.
41. Fridkis-Hareli M., Strominger JL Promiscuous binding of synthetic copolymer 1 to purified HLA-DR molecules. J Immunol 1998 ; 160: 4386-4397.
42. Duda PW, Schmied MC, Cook SL, Krieger JI, Hafler DA Glatiramer acetate (Copaxone) induces degenerate, Th2-polarized immune responses in patients with multiple sclerosis. J Clin Invest 2000 ; 105: 967-976.
43. Karandikar NJ, Crawford MP, Yan X., et al. Glatiramer acetate (Copaxone) therapy induces CD8(+) T cell responses in patients with multiple sclerosis. J Clin Invest 2002 ; 109: 641-649.
44. Weber MS, Hohlfeld R., Zamvil SS Mechanism of action of glatiramer acetate in treatment of multiple sclerosis. Neurotherapeutics 2007 ; 4: 647-653.
45. Tejada-Simon MV, Zang YC, Yang D., et al. Aberrant T cell responses to myelin antigens during clinical exacerbation in patients with multiple sclerosis. Int Immunol 2000 ; 12: 1641-1650.